DilutionScan

Trading small caps? Know the dilution. DilutionScan reads the SEC filings so you don't have to: • Every warrant, convertible, ATM and shelf, linked to the filing it came from • Dilution ratings: overall risk, offering ability, overhead supply, history and cash need • A dilution screener across every company we cover • A live filings feed showing what changed in each filing • Cash position and runway from the latest 10-Q/10-K • Float and shares outstanding, measured from SEC filings • Upcoming reverse splits Available on web, iOS and Android. Links below 👇

🗓️ WEEK IN DILUTION · Oct 26-30 🔴 $XXII $18.8M ATM (~1,403% of mkt cap) 🔴 $ACTU ~$11.0M at $0.71/2 shares (~59% of mkt cap) 🔴 $OSS $50.0M ATM sales (~39% of mkt cap) 🔴 $OPNW $3.5M at $1.39 (~28% of mkt cap) 🔴 $HYFM ~$1.45M at $0.905 (~16% of mkt cap) 🔴 $MGN up to $7.5M at $0.50 (~11% of mkt cap) 🔴 $INMB $4.5M at $1.50 (~11% of mkt cap) 7 sub-$300M offerings priced this week, tracked by Signal8.

📊 TODAY'S DILUTION · Fri Oct 30 📄 $PARA $11.75M S-1 offering (733% of market cap) 📄 $BLNK $100.0M ATM shelf (~172% of market cap) 🟢 $ALLR ELOC terminated ($6.0M capacity) 🔴 $VRME $3.5M priced offering (30% of market cap) 📝 $CAPS 333.3K shares resale (36.3% of shares outstanding) 📝 $MOBX 6.0M shares resale (20.3% of shares outstanding) 📝 $DWTX 4.1M shares resale S-3 📄 $ICU S-3 warrant resale filed +1 more 9 sub-$300M filings tracked by Signal8 today.

📝 RESALE REGISTERED $MOBX · Mobix Labs Technology · Nano cap ($13.2M) Resale: 6.0M shares (20.3% of 23.6M shares outstanding) Converts: Series A 10% Preferred, floating/discounted price ($0.64-$0.92 recent notes) Potential warrant proceeds: up to $9.8M (company receives only on exercise) Nasdaq deficiency: bid price below $1.00 as of Oct 9, 2026; split 1:2 to 1:20 approved S-1 registers 6.0M Class A shares issuable to Kips Bay Select upon conversion of Series A Preferred; company receives no proceeds from resale; going concern disclosed.

🗳️ SHARE INCREASE VOTE $ENSC · Ensysce Biosciences Healthcare · Nano cap ($8.19M) Auth. shares: 250.0M -> 500.0M Conversion: ~358M new shares (~95% of post-conversion shares outstanding) PIPE: ~$43.0M (two tranches; $21.5M initial close) Split range: 1-for-10 to 1-for-30 (board discretion) Nasdaq deficiency: bid price; deadline Feb 22, 2027; prior 1-for-15 split Dec 2024 PRE 14A for Dec 23 annual meeting seeks approval to convert Series C Preferred from the Aug 2026 reverse merger with Cy Biopharma and concurrent PIPE, increase authorized shares, and effect a reverse split to meet Nasdaq's $4.00 initial listing price requirement.

📝 RESALE REGISTERED $CAPS · Capstone Holding Industrials · Nano cap ($2.04M) Resale: 333.3K shares (36.3% of 917.9K shares outstanding) Equity line: up to $20.0M total; $18.3M remaining drawable Purchase price: greater of lowest trade or 90% of VWAP Agent: Joseph Gunnar, 7.0% fee Prior split: 1-for-30 (Oct 19, 2026) S-1 registers 333,333 shares issuable to Tumim Stone Capital under its equity line purchase agreement; going concern disclosed and 3i, LP convertible note matured Oct 22 with Event of Default declared.

📄 SHELF FILED $BLNK · Blink Charging Technology · Micro cap ($58.0M) Capacity: up to $100.0M ATM (~172% of market cap) Shares outstanding: 145.2M Agent: H.C. Wainwright, Roth Capital, StoneX, 3.0% commission Nasdaq deficiency: bid price below $1.00, cure deadline Jan 25, 2027 S-3 shelf and paired 424B5 ATM prospectus supplement filed Oct 30; company has notified Nasdaq it may effect a reverse stock split to regain compliance.

📄 OFFERING FILED $PARA · Parabolic Technologies Technology · Nano cap ($1.60M) Raise: $11.75M gross (733% of market cap) Warrants: 2 per unit at 250% of unit price, 5yr; reset day 5 to 80% lowest VWAP (floor 50% NMP), day 10 to 80% (floor 30% NMP); zero-exercise-price option for 90% of shares Agent: Aegis Capital Corp. Cumulative reverse split: 1-for-2,000 (three splits) S-1 for firm-commitment units offering; Nasdaq Staff Delisting Determination received Oct 27 for bid price failure, trading suspension set Nov 5 unless appealed; going concern disclosed; operating loss $18.5M in 2025.

🗳️ REVERSE SPLIT VOTE $FNGR · FingerMotion Technology · Nano cap ($10.4M) Split range: 1-for-10 to 1-for-100 (cumulative, Board discretion, 24-month window) Shares outstanding: 91.9M (as of Oct 13, 2026) Nasdaq deficiency: Rule 5550(a)(2) bid price below $1.00 Meeting: Dec 4, 2026 PRE 14A for Dec 4 special meeting; filing warns a second deficiency after the split would bar a new 180-day cure period under Rule 5810(c)(3)(A)(iv); largest holder Alto Opportunity Master Fund (9.99%) holds primarily via convertible notes and warrants.

🗳️ REVERSE SPLIT VOTE $AMSS · AMASS Brands Technology · Nano cap ($3.44M) Split range: 1-for-2 to 1-for-20 (board discretion) Shares outstanding: 11.6M (as of Jun 30, 2026) Nasdaq deadline: Apr 7, 2027 (bid price deficiency since Oct 9, 2026) Also deficient: $50M market value of listed securities; $15M publicly held shares Meeting: Dec 10, 2026 PRE 14A for Dec 10 special meeting; split alone cannot cure the market-value or publicly held share deficiencies, and a ratio of 1-for-10 or higher could itself push publicly held shares below Nasdaq minimums.

📝 RESALE REGISTERED $VACI · NorthStar Earth & Space Micro cap ($242M) Resale: 28.1M shares (68.1% of 41.3M shares outstanding) Warrants: 220.0K registered; 2.2M shares issuable at $11.50 Potential warrant proceeds: up to $25.5M (to company, cash exercise only) F-1 registers 28.1M selling-stockholder shares and 2.2M warrant shares from the Oct 1, 2026 de-SPAC merger with Viking Acquisition Corp. I; company receives no proceeds from resale.

🗳️ REVERSE SPLIT VOTE $CPHI · China Pharma Holdings Healthcare · Nano cap ($26.9M) Split range: up to 1-for-50 (board discretion) Prior split: 1-for-10 on Apr 15, 2025 (cumulative up to 500:1 if both max) Shares outstanding: 43.0M LTIP increase: 569,600 -> 8.6mln shares (+8.0M) Meeting: Dec 22, 2026 PRE 14A for Dec 22 annual meeting; NYSE American Section 1003(f)(vi) warns cumulative 200:1 or more in two years triggers immediate delisting with no cure period; company also relies on $1.78M in related-party loans from Chairperson Zhilin Li.

🟠 NEW ATM PROGRAM $APVO · Aptevo Therapeutics Healthcare · Nano cap ($2.43M) Capacity: up to $2.3M remaining (baby shelf cap: 1/3 of $6.9M public float) Sold to date: 303.2K shares for $11.8M gross Agent: Roth Capital Partners 424B5 amends the existing at-the-market sales agreement, restoring capacity to sell up to $2.31mln of common stock; the I.B.6 cap limits primary sales to one-third of the $6.93mln public float.

🗳️ SHARE INCREASE VOTE $MDCX · Medicus Pharma Healthcare · Nano cap ($2.70M) Auth. shares: unlimited blank-check Class A Preferred (new class) Split range: up to 50:1 forward split (board discretion) Shares outstanding: 1.89M (post Oct 12 50:1 consolidation) Record holders: 201 Meeting: Dec 2, 2026 DEF 14A for Dec 2 special meeting proposes creation of unlimited blank-check preferred shares and a forward split of up to 50:1, which the filing warns could push the stock back below the $1.00 Nasdaq minimum bid price.

📝 RESALE REGISTERED $ICU · SeaStar Medical Healthcare · Nano cap ($11.8M) Resale: 1.77M shares (warrant exercise, 33% of 5.32M shares outstanding) Warrants: 854.0K Series A at $3.616; 854.0K Series B at $3.616; 59.8K agent at $4.8325 Potential cash exercise: ~$6.5M (company receives proceeds only on exercise) Going concern: auditor consent reiterates FY2025 language S-3 registers 1.77mln shares issuable upon exercise of warrants issued in an October 2026 warrant inducement deal; selling stockholders include 3i, BPY, Nomis Bay, and H.C. Wainwright affiliates.

🔒 PRIVATE PLACEMENT $ALDS · APPlife Digital Solutions Technology · Nano cap ($328K) Converts: $60.0K note (10% OID), $46.7K net proceeds Rate: 12% one-time charge; 150% acceleration on default Conversion: 65% of lowest 20-day price (reducible to 50% on liquidity shortfall) Auth. shares: 20.0M -> 990.0M increase via Schedule 14C (~49x) Reserve: 1.75M shares initial; step-up of 7.1M on next auth. increase 8-K Items 1.01/2.03/3.02: convertible note issued Oct 26 to 104, LLC; going concern disclosed; preliminary Schedule 14C filed Oct 20 to expand authorized shares.

🔴 OFFERING PRICED $VRME · OpenWorld Technology · Nano cap ($11.8M) Raise: $3.5M gross (30% of market cap) Shares: 1.49M at $1.39 + 1.02M pre-funded at $0.0001 (0% vs prior close) Warrants: 2.52M Series A at $1.53, 5yr; 2.52M Series B at $1.39, 18mo (shareholder approval required) Agent: Maxim Group, 7.0% fee Dilution: 18.7% of 13.47M shares pre-offering 424B5: registered direct offering of 1.49M shares and 1.02M pre-funded warrants; proceeds for RWA growth initiatives and working capital; Nasdaq audit-committee deficiency notice received Oct 26.

🔒 PRIVATE PLACEMENT $GRRR · Gorilla Technology Group Technology · Micro cap ($251M) Converts: $27.775M note (10% OID), $25.0M gross initial close Fixed price: $17.5308; alt. 90% of 3 lowest VWAPs, floor $3.858 Warrants: 850.6K at $12.8995, 5yr; + 1.0M pre-delivery shares Auth. shares: 73.5M -> 200M increase required (special meeting, 75 days) Total facility: up to $111.1M principal / $100.0M funding 6-K: securities purchase agreement dated Oct 29 with one institutional investor; senior convertible notes for data center advance payments with Yotta Data Services; registration-delay liquidated damages 2.0% of principal per 30 days.

✂️ SPLITS & UPLISTINGS TODAY · Fri Oct 30 ✂️ $IVF 1-for-4 reverse split (INVO Fertility) ✂️ $MASK 1-for-4 reverse split (3 E Network Technology) ⬆️ solana:2jrPeHZ9wt2pBTxPEuyNzDtJRTQDEbWhSoXYWsLHpump OTC -> Nasdaq (Nordicus Partners, new symbol not yet resolved) (provisional)

🌅 OVERNIGHT DILUTION · Fri Oct 30 ⚡ $BTLN S-3 shelf effective (Brightline Interactive, $9.89M) ⚡ $RCT S-3 effective (RedCloud Holdings, $6.89M) 2 sub-$300M registrations declared effective overnight, tracked by Signal8.

🗳️ REVERSE SPLIT VOTE $DVLT · Datavault AI Technology · Micro cap ($76.1M) Split range: 1-for-2 to 1-for-50 (Board discretion, 12-month window) Shares outstanding: 1.03B Nasdaq deadline: Feb 22, 2027 (bid price deficiency since Feb 2026) Also voting: Streeterville Capital convertible note share issuances (Rule 5635(d)) PRE 14A for Dec 16, 2026 annual meeting; reverse split proposed to regain Nasdaq minimum bid price compliance.